BACKGROUND: Cardiac allograft vasculopathy (CAV) is a multifactorial pathology limiting the survival of cardiac transplants. The etiology of CAV is unclear, but antibody-mediated and cellular-mediated responses have been implicated. We, and others, have observed ectopic lymphoid structures (ELS) surrounding epicardial coronary arteries with CAV. The potential contribution of these ELS to CAV has not been elucidated. METHODS: Epicardial coronary arteries were collected from 59 transplant patients at 2 centers and studied for ELS presence and composition using immunohistochemistry. The intima and ELS were isolated, and the expression of the genes involved in tertiary lymphoid organ (TLO) formation was measured by quantitative polymerase chain...
Cardiac allograft vasculopathy (CAV) has a high prevalence among patients that have undergone heart ...
Graft vasculopathy is an accelerated form of coronary artery disease that occurs in transplanted hea...
Cardiac transplantation is currently the preferred choice of treatment for end-stage cardiac disease...
Cardiac allograft vasculopathy (CAV) is a transplant pathology, limiting graft survival after heart ...
Cardiac allograft vasculopathy (CAV) is a transplant pathology, limiting graft survival after heart ...
Cardiac Allograft Vasculopathy (CAV) is a disease which has a high prevalence in Heart transplant (H...
Cardiac Allograft Vasculopathy (CAV) is a disease which has a high prevalence in Heart transplant (H...
Cardiac allograft vasculopathy (CAV) limits the long-term success of heart transplants. Generation o...
Cardiac allograft vasculopathy (CAV) is one of the main causes of late-stage heart failure after hea...
Item does not contain fulltextINTRODUCTION: Long-term survival after heart transplantation (HTx) is ...
Abstract Cardiac allograft vasculopathy (CAV) is one of the main causes of late-stage heart failure ...
Introduction: Long-term survival after heart transplantation (HTx) is hampered by cardiac allograft ...
BACKGROUND: Antibodies to endothelial derived non-human leukocyte antigens (HLA) have been associate...
BACKGROUND: Circulating progenitor cells (PCs) may play a role in the pathogenesis of cardiac allogr...
BACKGROUND: Circulating progenitor cells (PCs) may play a role in the pathogenesis of cardiac allogr...
Cardiac allograft vasculopathy (CAV) has a high prevalence among patients that have undergone heart ...
Graft vasculopathy is an accelerated form of coronary artery disease that occurs in transplanted hea...
Cardiac transplantation is currently the preferred choice of treatment for end-stage cardiac disease...
Cardiac allograft vasculopathy (CAV) is a transplant pathology, limiting graft survival after heart ...
Cardiac allograft vasculopathy (CAV) is a transplant pathology, limiting graft survival after heart ...
Cardiac Allograft Vasculopathy (CAV) is a disease which has a high prevalence in Heart transplant (H...
Cardiac Allograft Vasculopathy (CAV) is a disease which has a high prevalence in Heart transplant (H...
Cardiac allograft vasculopathy (CAV) limits the long-term success of heart transplants. Generation o...
Cardiac allograft vasculopathy (CAV) is one of the main causes of late-stage heart failure after hea...
Item does not contain fulltextINTRODUCTION: Long-term survival after heart transplantation (HTx) is ...
Abstract Cardiac allograft vasculopathy (CAV) is one of the main causes of late-stage heart failure ...
Introduction: Long-term survival after heart transplantation (HTx) is hampered by cardiac allograft ...
BACKGROUND: Antibodies to endothelial derived non-human leukocyte antigens (HLA) have been associate...
BACKGROUND: Circulating progenitor cells (PCs) may play a role in the pathogenesis of cardiac allogr...
BACKGROUND: Circulating progenitor cells (PCs) may play a role in the pathogenesis of cardiac allogr...
Cardiac allograft vasculopathy (CAV) has a high prevalence among patients that have undergone heart ...
Graft vasculopathy is an accelerated form of coronary artery disease that occurs in transplanted hea...
Cardiac transplantation is currently the preferred choice of treatment for end-stage cardiac disease...